Elective percutaneous coronary intervention without on-site cardiac surgery: Clinical and economic implications

Medical Care

Volumn 44, Issue 5, 2006, Pages 406-413

  Long, Kirsten Hall ^a   McMurtry, Erin K ^a   Lennon, Ryan J ^a   Chapman, Anne C ^b   Singh, Mandeep ^a   Rihal, Charanjit S ^a   Wood, Douglas L ^a   Holmes Jr , David R ^a   Ting, Henry H ^a  

^a MAYO CLINIC   (United States)

^b ALBERT LEA EYE CLINIC   (United States)

Author keywords

Cost; Outcomes; Percutaneous coronary intervention; Quality; Telemedicine

Indexed keywords

ARTICLE; CATHETER ABLATION; COHORT ANALYSIS; COMMUNITY HOSPITAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; ECONOMICS; ELECTIVE SURGERY; EVALUATION; FEMALE; HEALTH CARE COST; HEART SURGERY; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; STATISTICS; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

CARDIAC CARE FACILITIES; CARDIAC SURGICAL PROCEDURES; CATHETER ABLATION; COHORT STUDIES; CORONARY DISEASE; FEMALE; HEALTH CARE COSTS; HOSPITALS, COMMUNITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MINNESOTA; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); SURGICAL PROCEDURES, ELECTIVE; SURVIVAL ANALYSIS;

EID: 33646785406     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000207489.13557.cc     Document Type: Article

References (38)

1. Berger PB, Stensrud PE, Daly RC, et al. Time to reperfusion and other procedural characteristics of emergency coronary artery bypass surgery after unsuccessful coronary angioplasty. Am J Cardiol. 1995;76:565-569.
2. McGrath PD, Wennberg DE, Dickens JD Jr, et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284:3139-3144.
3. Ellis SG, Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 1997;95:2479-2484.
4. Lincoff AM, Califf RM, Moliterno DJ, et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. N Engl J Med. 1999;341:319-327.
5. Stone GW, Grines CL, Cox DA, et al. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957-966.
6. ESPRIT Investigators. Enhanced suppression of the platelet IIb/IIIa receptor with integrilin therapy. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet. 2000;356:2037-2044.
7. O'Shea JC, Hafley GE, Greenberg S, et al. Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA. 2001;285:2468-2473.
8. Seshadri N, Whitlow PL, Acharya N, et al. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 2002;106:2346-2350.
9. Hasdai D, Berger PB, Bell MR, et al. The changing face of coronary interventional practice. The Mayo Clinic experience. Arch Intern Med. 1997;157:677-682.
10. Loubeyre C, Morice MC, Berzin B, et al. Emergency coronary artery bypass surgery following coronary angioplasty and stenting: results of a French multicenter registry. Catheter Cardiovasc Interv. 1999;47:441-448.
11. McGrath PD, Malenka DJ, Wennberg DE, et al. Changing outcomes in percutaneous coronary interventions: a study of 34,752 procedures in northern New England, 1990 to 1997. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 1999;34:674-680.
12. Wennberg DE, Lucas FL, Siewers AE, et al. Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery. JAMA. 2004;292:1961-1968.
13. Singh M, Ting HH, Gersh BJ, et al. Percutaneous coronary intervention for ST-segment and non-ST-segment elevation myocardial infarction at hospitals with and without on-site cardiac surgical capability. Mayo Clin Proc. 2004;79:738-744.
14. Wharton TP Jr, Grines LL, Turco MA, et al. Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty. J Am Coll Cardiol. 2004;43:1943-1950.
15. Smyth DW, Richards AM, Elliott JM. Direct angioplasty for myocardial infarction: one-year experience in a center with surgical back-up 220 miles away. J Invasive Cardiol. 1997;9:324-332.
16. Wharton TP Jr, McNamara NS, Fedele FA, et al. Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery. J Am Coll Cardiol. 1999;33:1257-1265.
17. Iannone LA, Anderson SM, Phillips SJ. Coronary angioplasty for acute myocardial infarction in a hospital without cardiac surgery. Tex Heart Inst J. 1993;20:99-104.
18. Vogel JH. Angioplasty in the patient with an evolving myocardial infarction: with and without surgical backup. Clin Cardiol. 1992;15:880-882.
19. Weaver WD, Litwin PE, Martin JS. Use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery. The Myocardial Infarction, Triage, and Intervention Project Investigators. Circulation. 1993;88:2067-2075.
20. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) - executive summary. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37:2215-2239.
21. Ting HH, Garratt KN, Singh M, et al. Low-risk percutaneous coronary interventions without on-site cardiac surgery: two years' observational experience and follow-up. Am Heart J. 2003;145:278-284.
22. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193-1202.
23. Holmes DR Jr, Vlietstra RE. Percutaneous transluminal coronary angioplasty: current status and future trends. Mayo Clin Proc. 1986;61:865-876.
24. Hasdai D, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336:755-761.
25. Rosenbaum PR. Optimal matching for observational studies. J Am Stat Assoc. 1989;84:1024-1032.
26. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
27. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hall/CRC; 1998.
28. Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998;3:233-245.
29. Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 2002;287:1943-1951.
30. Zahn R, Schiele R, Schneider S, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol. 2000;36:2064-2071.
31. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-742.
32. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
33. Cannon CP. Primary percutaneous coronary intervention for all? JAMA. 2002;287:1987-1989.
34. Kansagra SM, Curtis LH, Schulman KA. Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance. JAMA. 2004;292:1717-1723.
35. Zavala-Alarcon E, Cecena F, Ashar R, et al. Safety of elective - including 'high risk' - percutaneous coronary interventions without onsite cardiac surgery. Am Heart J. 2004;148:676-683.
36. Kastrati A, Mehilli J, Schuhlen H, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med. 2004;350:232-238.
37. Eagle KA, Knight BP, Moscucci M, et al. Competitive bidding for interventional cardiology supplies: lessons learned during round 2. Am J Manag Care. 2002;8:384-388.
38. Moscucci M, Muller DW, Watts CM, et al. Reducing costs and improving outcomes of percutaneous coronary interventions. Am J Manag Care. 2003;9:365-372.